Professor John Amory
speaker
76 appearances
1 recordings
1 series
first heard May 2026
last heard 1 May
Professor John Amory’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.
Appearances
These hormonal approaches, especially long-acting injections, were tested very extensively in China in the mid-2000s.
And one thing about these hormonal methods is they tend to be more effective in men of Asian descent.
So we all thought, oh, that'll get approved.
At the last minute, the regulatory body said, not going to approve it.
Didn't make it clear why.
So sometimes there's a shroud over these things we don't fully understand.
Right.
That's the most notorious case that I'm aware of.
Others have had issues with sort of acceptability, efficacy, safety, the usual things.
It's one of the challenges, and I don't mean to be overly critical of the regulatory bodies, because if I were in their shoes, there's no precedent here.
The risk is to the user, but the benefit is to another person.
I'm not aware of a medication or medical intervention that works in that way.
It's kind of a unique medical ethics situation.
So I think that has played into the regulatory stasis, if you will.
My pleasure.
Thank you for having me and for the great questions and your interest in male contraceptive development.
Showing 61–76 of 76 · page 4 of 4
← Previous